![](/img/cover-not-exists.png)
CPX-351 for the Treatment of Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC): An Analysis of Clinical Benefit
Chung, KC, Ryan, RJ, Louie, ACVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.087
Date:
May, 2018
File:
PDF, 81 KB
english, 2018